Drugs / PEP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04327635 | Nov 2021 → Oct 2025 | — | Christopher J. McLeod | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04327635 ↗ |
| Modality | Other / unclassified | “single purified exosome product (PEP) injection” PMID 33620904 ↗ Mar 2021 |